Epidiolex, the First Cannabis Medicine in the U.S., to be on Sale Within Six Weeks

On Thursday (Sep. 27), the Drug Enforcement Administration officially moved the cannabis-based drug Epidiolex into a “Schedule V” classification, a category for substances with the lowest abuse potential, such as cough medicines. The country’s first-ever cannabis-based prescription drug will now hit the markets within six weeks.

The company who manufactures this drug, GW Pharmaceuticals, saw its U.S.-listed shares rise 8 percent after the news was announced.

Epidiolex is made from…

Click to read the full article

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.